... equilibrium configuration on the assumption that there is a harmonization of patent laws according to TRIPs so that patent protection is similar in both developed and developing countries In section 2.3, ... to the returns to pharmaceutical research, and to the consumer surplus in developed and developing countries Section 2.4 is an extension where we endogenize the time taken for a me-too drug to ... Salkever, 1992 and 1997; Suh et al., 2000; Ellison and Ellison, 2000; Danzon and Chao, 2000) Grabowski and Vernon (1990) studied the effect of generic entry on 18 drugs between 1984 and 1987 and found...